Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
Vittorio Mantero(Aziende Socio Sanitarie Territoriali di Lecco), Christian Cordano(University of California, San Francisco), Damiano Baroncini, Andrea Salmaggi, Roberto Balgera, Paola Basilico(Aziende Socio Sanitarie Territoriali di Lecco), Pietro Annovazzi(Vita-Salute San Raffaele University), Clara Guaschino, Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla)
Cited by 26
Related Papers
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268
Prospective study of multiple sclerosis with early onset
|Multiple Sclerosis Journal|2002|152